Five9, Inc. (FIVN)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,024	3,056	5,720	4,784	9,344	11,507
Market Cap Growth	-38.00%	-46.57%	19.56%	-48.80%	-18.79%	187.28%
Enterprise Value	2,188	3,326	5,816	4,996	9,548	11,383
Last Close Price	26.20	40.64	78.69	67.86	137.32	174.40
Forward PE	8.82	16.41	41.81	49.09	123.88	237.86
PS Ratio	1.79	2.93	6.28	6.14	15.33	26.46
PB Ratio	2.82	4.91	10.63	15.44	44.26	41.22
P/TBV Ratio	6.92	15.99	21.00	41.12	1606.96	185.42
P/FCF Ratio	14.21	30.33	58.61	130.75	-	312.02
P/OCF Ratio	11.61	21.35	44.40	53.84	322.25	170.98
PEG Ratio	0.66	0.86	1.71	2.09	5.12	13.24
EV/Sales Ratio	1.98	3.19	6.39	6.41	15.66	26.17
EV/EBITDA Ratio	31.05	141.52	-	-	-	890.56
EV/EBIT Ratio	161.62	-	-	-	-	-
EV/FCF Ratio	15.35	33.01	59.59	136.52	-	308.65
Debt / Equity Ratio	1.11	1.98	1.48	2.55	3.91	2.34
Debt / EBITDA Ratio	9.52	33.53	-	-	-	34.52
Debt / FCF Ratio	5.61	12.24	8.13	21.60	-	17.71
Asset Turnover	0.61	0.59	0.67	0.64	0.54	0.56
Quick Ratio	3.80	1.76	4.97	4.68	3.53	6.31
Current Ratio	4.44	1.95	5.53	5.17	3.92	6.65
Return on Equity (ROE)	1.42%	-2.21%	-19.28%	-36.33%	-21.62%	-17.72%
Return on Assets (ROA)	0.47%	-1.04%	-4.19%	-4.48%	-2.80%	-1.00%
Return on Capital (ROIC)	0.52%	-1.15%	-4.72%	-5.11%	-3.21%	-1.14%
Return on Capital Employed (ROCE)	0.90%	-	-	-	-	-
Earnings Yield	0.44%	-0.42%	-1.43%	-1.98%	-0.57%	-0.37%
FCF Yield	7.04%	3.30%	1.71%	0.77%	-0.14%	0.32%
Buyback Yield / Dilution	-12.03%	-3.41%	-3.04%	-3.57%	-5.23%	-6.27%

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q